CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops a novel RNA delivery platform to address the challenges of treating rare genetic diseases. It focuses on creating safe, biodegradable peptide carriers that enhance the delivery of nucleic acid therapeutics to targeted tissues.
TraffikGene-Tx:
Targeted and Dynamic RNA Peptide Vehicles-Unmet Clinical Need and ProblemRare and complex genetic diseases lead to significant disability, death and associated cost burdens for society.
Complex genetic diseases include cardiovascular diseases (CVD) and cancer, the two leading causes of death in the EU and up to 36 million Europeans suffer from rare genetic diseases.
Nucleic acid therapeutics (NATs) represent a potential treatment, but they are hampered by the delivery problem.
Sy…
UNIVERSIDADE DE SANTIAGO DE COMPOSTELA
UNIVERSIDAD DE SANTIAGO DE COMPOSTELA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
